PharVision Advisers’s Booking.com BKNG Stock Holding History

PharVision Advisers’s Portfolio BKNG Stock Details BKNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,300	Closed	-$301K	–	669
2025 Q2	$301K	Buy	+1,300	New	+$266K	0.43%	80

Other funds holding BKNG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

PharVision Advisers's BKNG Position: Q3 2025 in Review

PharVision Advisers sold out of Booking.com (BKNG) in Q3 2025, closing a stake of 1,300 shares — an estimated $301K sold.

PharVision Advisers first reported a position in BKNG in Q2 2025 and held it in 1 quarter. The position peaked at $301K in Q2 2025. 1,932 funds tracked by Wall St. Rank hold BKNG as of Q3 2025.

PharVision Advisers reported no remaining Booking.com position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 1,300 Booking.com shares in Q3 2025, an estimated $301K.
PharVision Advisers first reported a position in Booking.com in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Booking.com position peaked at $301K in Q2 2025.
1,932 funds tracked by Wall St. Rank held Booking.com as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.